Max Robotics — Global Service Robot Directory + US Certification

About

Yingyi Qin is a urologic surgeon-researcher whose work centers on optimizing surgical outcomes for prostate cancer, with a particular focus on robot-assisted laparoscopic radical prostatectomy (RALRP). His research critically examines how patient-specific factors—such as morbid obesity and HIV status—influence perioperative risks and recovery. In a landmark 2020 study (20 citations), Qin demonstrated that morbid obesity is significantly associated with adverse perioperative outcomes following RALRP, providing crucial evidence for preoperative risk stratification. He also conducted a comprehensive nationwide comparison of robot-assisted versus open radical prostatectomy using the Nationwide Inpatient Sample (2009–2014), revealing superior perioperative outcomes for the robotic approach (11 citations). Additionally, his pioneering analysis of RALRP outcomes in HIV-positive patients (5 citations) addressed an underserved population, showing that robotic surgery can be performed safely in this group. By leveraging large-scale national databases, Qin’s work provides high-level evidence that directly informs clinical decision-making and surgical planning. His contributions have helped refine patient selection, improve surgical safety, and expand access to minimally invasive prostate cancer surgery.